Clinical backgrounds and morbidity of cognitive impairment in elderly diabetic patients

Endocrine Journal

Volumn 58, Issue 2, 2011, Pages 109-115

  Yamazaki, Yasunori ^a   Miwa, Takashi ^a   Sakurai, Hirofumi ^a   Hanyu, Haruo ^a   Iwamoto, Toshihiko ^a   Odawara, Masato ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Cognitive impairment; Diabetes mellitus; Mini mental state examination (MMSE)

Indexed keywords

CHOLESTEROL; DIURETIC AGENT; NON HIGH DENSITY LIPOPROTEIN CHOLESTEROL; UNCLASSIFIED DRUG;

AGED; ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; ARTICLE; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; ELDERLY CARE; FEMALE; FRAIL ELDERLY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MIXED DEPRESSION AND DEMENTIA; MORBIDITY; MULTIINFARCT DEMENTIA; NON INSULIN DEPENDENT DIABETES MELLITUS;

AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; ALZHEIMER DISEASE; CEREBROVASCULAR DISORDERS; COGNITION DISORDERS; DEMENTIA; DEMENTIA, VASCULAR; DIABETES MELLITUS, TYPE 2; DIURETICS; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS;

EID: 79952718688     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K10E-388     Document Type: Article

References (23)

1. Yoshitake T, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K, Ohmori S, Nomiyama K, Kawano H, Ueda K, et al. (1995) Incidence and risk factors of vascular dementia and Alzheimer's disease in a deined elderly Japanese population: the Hisayama Study. Neurology 45(6): 1161-1168.
2. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM (1999) Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 53(9): 1937-1942.
3. Peila R, Rodriguez BL, Launer LJ (2002) Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes 51(4): 1256-1262.
4. Lu FP, Lin KP, Kuo HK (2009) Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis. PLoS One 4(1): e4144.
5. Homma A, Fukuzawa K, Tsukada Y, Ishii T, Hasegawa K, Mohs RC (1992) Development of a Japanese version of Alzheimer's Disease Assessment Scale (ADAS). Jpn J Geriatr Psychiatry 3(6): 647-655 (In Japanese).
6. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34(7): 939-944.
7. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST (2001) Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56(9): 1133-1142.
8. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, et al. (1993) Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43(2): 250-260.
9. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M (2005) Global prevalence of dementia: a Delphi consensus study. Lancet 366(9503): 2112-2117.
10. Levey A, Lah J, Goldstein F, Steenland K, Bliwise D (2006) Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease. Clin Ther 28(7): 991-1001.
11. Yaffe K, Blackwell T, Whitmer RA, Krueger K, Barrett Connor E (2006) Glycosylated hemoglobin level and development of mild cognitive impairment or dementia in older women. J Nutr Health Aging 10(4): 293-295.
12. Luck T, Luppa M, Briel S, Riedel Heller SG (2010) Incidence of mild cognitive impairment: a systematic review. Dement Geriatr Cogn Disord 29(2): 164-175.
13. Cukierman Yaffe T, Gerstein HC, Anderson C, Zhao F, Sleight P, Hilbrich L, Jackson SH, Yusuf S, Teo K (2009) Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: results from the ONTARGET/TRANSCEND research programme. Diabetes Res Clin Pract 83(3): 387-393.
14. Ebady SA, Arami MA, Shaigh MH (2008) Investigation on the relationship between diabetes mellitus type 2 and cognitive impairment. Diabetes Res Clin Pract 82(3): 305-309.
15. Shimada H, Miki T, Tamura A, Ataka S, Emoto M, Nishizawa Y (2010) Neuropsychological status of elderly patients with diabetes mellitus. Diabetes Res Clin Pract 87: 224-227.
16. Folstein MF, Folstein SE, McHugh PR (1975) "Minimental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198.
17. Tombaugh TN, McIntyre NJ (1992) The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 40: 922-935.
18. Luchsinger JA, Tang MX, Siddiqui M, Shea S, Mayeux R (2004) Alcohol intake and risk of dementia. J Am Geriatr Soc 52: 540-546.
19. Letenneur L, Larrieu S, Barberger Gateau P (2004) Alcohol and tobacco consumption as risk factors of dementia: a review of epidemiological studies. Biomed Pharmacother 58: 95-99.
20. MRC Working Party (1992) Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 304(6824): 405-412.
21. Zhong N, Weisgraber KH (2009) Understanding the association of apolipoprotein E4 with Alzheimer disease: clues from its structure. J Biol Chem 284: 6027-6031.
22. Martins CA, Oulhaj A, de Jager CA, Williams JH (2005) APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model. Neurology 65: 1888-1893.
23. Singh Manoux A, Gimeno D, Kivimaki M, Brunner E, Marmot MG (2008) Low HDL cholesterol is a risk factor for deicit and decline in memory in midlife: the Whitehall II study. Arterioscler Thromb Vasc Biol 28: 1556-1562.